Author

V. Petrosyan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Milosavljevic· 2 shared L. E. Dobrolecki· 2 shared M. T. Lewis· 2 shared A. B. Saltzman· 1 shared A. Malovannaya· 1 shared A. N. Lewis· 1 shared A. Pavlick· 1 shared A. Welm· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Milosavljevic

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

XDec Simplex Map of Breast Cancer Cell States Enables Precise Modeling and Targeting of Breast Cancer

O. D. Murillo, V. Petrosyan, E. L. LaPlante, L. E. Dobrolecki, M. T. Lewis, A. Milosavljevic

XDec-SM maps breast tumors to a low-dimensional space using bulk RNA-seq, inferring cell states and their associations with mutations and metabolism, and predicting therapy response.

bioRxiv · Jul 6, 2022 · PreprintCancer Biology

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

V. Petrosyan, L. E. Dobrolecki, L. Thistlethwaite, A. N. Lewis, C. Sallas, R. Rajaram, J. T. Lei, M. J. Ellis, K. Osborne, M. Rimawi, A. Pavlick, M. Shafaee, H. Dowst, A. B. Saltzman, A. Malovannaya, , M. T. Lewis

This paper identifies biomarkers of differential chemotherapy response in TNBC using a network-based approach and validates them in PDX models and clinical datasets.

bioRxiv · Aug 20, 2021 · PreprintCancer Biology